Adult respiratory distress syndrome as a severe immune reconstitution disease following the commencement of highly active antiretroviral therapy

We report a patient who developed adult respiratory distress syndrome (ARDS) secondary to Mycobacterium tuberculosis as an immune reconstitution disease. This complication occurred 14 days after the commencement of highly active antiretroviral therapy (HAART) for advanced HIV infection. The case emp...

Full description

Saved in:
Bibliographic Details
Published in:Sexually transmitted infections 2003-08, Vol.79 (4), p.337-338
Main Authors: Goldsack, N R, Allen, S, Lipman, M C I
Format: Article
Language:English
Subjects:
Acute respiratory distress syndrome
Adult
Antiretroviral drugs
Antiretroviral Therapy, Highly Active - adverse effects
Biological and medical sciences
Care and treatment
Case Report
Case studies
Complications and side effects
Cytomegalovirus
Disease
Drug therapy
Highly active antiretroviral therapy
HIV
HIV Infections - complications
HIV Infections - drug therapy
HIV patients
Human immunodeficiency virus
Human viral diseases
Humans
Immunopathology
Infections
Infectious diseases
Inflammation
Intensive care
Male
Medical sciences
Pneumology
Respiratory distress syndrome
Respiratory Distress Syndrome, Adult - etiology
Respiratory Distress Syndrome, Adult - immunology
Respiratory system : syndromes and miscellaneous diseases
Risk factors
Tuberculosis
Viral diseases
Viral diseases of the lymphoid tissue and the blood. Aids
X-rays
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We report a patient who developed adult respiratory distress syndrome (ARDS) secondary to Mycobacterium tuberculosis as an immune reconstitution disease. This complication occurred 14 days after the commencement of highly active antiretroviral therapy (HAART) for advanced HIV infection. The case emphasises that immune reconstitution can be an extremely aggressive complication of HAART.
ISSN:1368-4973
1472-3263
DOI:10.1136/sti.79.4.337